Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

The latest NICE guidelines on asthma emphasize FeNO testing. Bedfont® provides resources and support for healthcare professionals implementing these changes.

Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023 – Biotech Investments

Medacta Group SA / Key word(s): Half Year Results/Half Year Results 22-Sep-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53

September 23, 2023

STAT unveils a new look, and color. Our executive editor explains why

Dear Readers, Today is an important day in the history of STAT: We have refreshed the look of our homepage and adjusted the teal color

June 27, 2023

M&A: Axxess Acquires Home Health EHR Complia Health

What You Should Know: – Home healthcare technology provider Axxess announced it has acquired Complia Health, a provider of EMR solutions, technology and services for

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.